Zoetis™ Celebrates IPO on the NYSE

Executives and guests of Madison, NJ-based Zoetis, a leading animal health company, will visit the New York Stock Exchange (NYSE) to celebrate the company’s initial public offering. Zoetis will begin trading today on the NYSE under the ticker symbol “ZTS.”

In honor of the occasion, Zoetis Chief Executive Officer Juan Ramón Alaix, joined by Zoetis colleagues, will ring the NYSE Opening Bell.

About Zoetis (NYSE: ZTS)

Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on a 60-year history as the animal health business of Pfizer, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, with a focus on both farm and companion animals.  The company generated annual revenue of $4.2 billion in fiscal 2011. Zoetis has more than 9,500 employees and a local presence in approximately 70 countries, including 29 manufacturing facilities in 11 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries. (Source: Zoetis)